Tirzepatide is a dual GIP/GLP-1 receptor agonist that has shown superior weight loss results compared to single GLP-1 medications. Available as Mounjaro and Zepbound, it's administered weekly and helps control appetite while improving blood sugar regulation.
Top-rated specialists in Tirzepatide treatment
Common questions about Tirzepatide treatment
Tirzepatide activates both GLP-1 and GIP receptors, which may lead to better weight loss results and blood sugar control compared to GLP-1-only medications.
Common side effects include nausea, vomiting, diarrhea, and decreased appetite. These usually decrease over time as your body adjusts to the medication.
Adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions may be candidates. Your provider will determine if it's right for you.
Connect with tirzepatide specialists who can help you achieve your health goals with personalized treatment plans.